Search results for "Highlights"

Results 61 - 70 of about 400 for "Highlights".
Sort by: Relevance | Newest | Oldest

Type 1 and type 2 diabetes associated with increased risk of herpes zoster

Results of a systematic review and meta-analysis were consistent across age groups, diabetes types, and regions of the world. The study authors suggested that earlier vaccination against herpes zoster in all patients with diabetes, regardless of age, be considered.
8 Oct 2021

Physician-patient discussions may decrease unnecessary self-monitoring of blood glucose levels

In a cross-sectional survey at an Ohio health system, 67% of respondents with non-insulin-controlled type 2 diabetes said they monitored their blood glucose levels because their physician had asked them to, and 50% said they would stop if given permission.
10 Sep 2021

GLP-1 receptor agonists improved cardiovascular, kidney outcomes in type 2 diabetes

In a systematic review and meta-analysis of eight randomized controlled trials, glucagon-like peptide-1 (GLP-1) receptor agonists reduced major adverse cardiovascular events by 14%, all-cause mortality by 12%, hospital admission for heart failure by 11%, and a composite kidney outcome by 21%, with no increase in safety outcomes.
10 Sep 2021

Antidepressant adherence linked to lower risk of advanced complications of diabetes

In patients with diabetes and depression in Taiwan, regular use of an antidepressant was associated with a 0.92-fold decreased risk of macrovascular complications and a 0.86-fold decreased risk of all-cause mortality compared with poor adherence.
13 Aug 2021

Diets with low glycemic index or glycemic load may benefit patients with diabetes

A systematic review and meta-analysis found small improvements in established targets for glycemic control, blood lipids, adiposity, and inflammation among those with moderately controlled type 1 and type 2 disease who tried low glycemic index/load diets.
13 Aug 2021

PPIs may have beneficial glycemic effects in patients with diabetes

A systematic review and meta-analysis found that proton-pump inhibitors (PPIs) improved glycemic indices in patients with diabetes and did not appear to affect risk for incident diabetes.
9 Jul 2021

Association between diabetes and worse COVID-19 outcomes more marked in younger adults

Among patients hospitalized with COVID-19, diabetes was a more significant risk factor for death, intensive care, or intubation in those younger than 50 years compared to older patients, a retrospective French study found.
11 Jun 2021

Depression associated with death in older patients with type 2 diabetes

A study that screened patients with type 2 diabetes in Spain for depression found that depression was associated with higher all-cause mortality in patients older than age 65 years, but not in younger patients.
11 Jun 2021

Younger age at type 2 diabetes onset linked to higher risk of subsequent dementia

An analysis of a prospective cohort study in the U.K. found that developing type 2 diabetes before age 70 years was associated with greater likelihood of having dementia, and dementia risk increased with longer duration of diabetes.
14 May 2021

SGLT-2 inhibitors associated with increased risk for diabetic ketoacidosis

A cohort study found a threefold increase in the risk for diabetic ketoacidosis with sodium-glucose cotransporter-2 (SGLT-2) inhibitors compared to dipeptidyl peptidase-4 (DPP-4) inhibitors, with possible variation by severity or duration of diabetes.
14 Aug 2020

Result Page: Prev   2   3   4   5   6   7   8   9   10   11   Next